HRA Pharma And Maxwellia To Launch The UK’s First OTC Daily Contraceptives

The UK's MHRA has approved the Rx-to-OTC switch of two identical progestogen-only contraceptive pills from HRA Pharma and Maxwellia. Hana and Lovima (both 75mcg desogestrel) will be launched at the end of the month. 

ContraceptivePill
• Source: Shutterstock

Thanks to a successful, simultaneous Rx-to-OTC switch of the progestogen-only contraceptive pill, HRA Pharma and Maxwellia are both poised to separately launch the first non-prescription daily contraceptives in the UK.

More from United Kingdom

More from Europe